Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting

NCT00125398 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00125398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Open-Label Study to Examine the Safety and Efficacy of GPI 15715 for Sedation of Patients Requiring Intubation and Mechanical Ventilation in the Intensive Care Unit Setting
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
May 31, 2007
Enrollment
60
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

intubation, postoperative sedation, respiration, artificial